Pacira BioSciences (PCRX) Net Cash Flow (2010 - 2026)
Pacira BioSciences (PCRX) posted quarterly Net Cash Flow of -$14.3 million for Q1 2026, down 308.85% year-over-year from $6.8 million in Q1 2025, and down 225.57% quarter-over-quarter from $11.4 million in Q4 2025.
Pacira BioSciences (PCRX) Net Cash Flow (2010 - 2026) Analysis & Trends
Pacira BioSciences' Net Cash Flow history runs 17 years deep, the most recent figure standing at -$14.3 million for Q1 2026.
- In Q1 2026, Net Cash Flow fell 308.85% year-over-year to -$14.3 million; the TTM figure through Mar 2026 stood at -$139.3 million (down 239.88% YoY), while the FY2025 annual figure was -$118.2 million, down 195.69% from the prior year.
- Net Cash Flow for Q1 2026 stood at -$14.3 million, down from $11.4 million in the prior quarter.
- The five-year high for Net Cash Flow was $63.0 million in Q2 2024, with the low at -$358.8 million in Q1 2022.
- The 5-year median for Net Cash Flow is $6.8 million (2025), against an average of -$26.0 million.
- The sharpest annual moves came in 2023 and 2025: Net Cash Flow soared 1125.15% in 2023, then plunged 13965.07% in 2025.
- Pacira BioSciences' Net Cash Flow stood at -$5.3 million in 2022, then jumped by 1125.15% to $54.2 million in 2023, then tumbled by 43.13% to $30.8 million in 2024, then slumped by 63.1% to $11.4 million in 2025, then sank by 225.57% to -$14.3 million in 2026.
- Business Quant data shows PCRX's Net Cash Flow at -$14.3 million in Q1 2026, $11.4 million in Q4 2025, and -$153.0 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn | -81.00 Mn |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn | -458.00 Mn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | -881.03 Mn |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn | 523.50 Mn |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn | -912.40 Mn |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn | 64.40 Mn |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn | 93.00 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | - |
| 10 | Pacira BioSciences | 970.37 Mn | 719.34 Mn | 148.24 Mn | 61.57 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 61.57 Mn |
| Jun 30, 2026 | 61.57 Mn |
| Mar 31, 2026 | -14.28 Mn |
| Mar 31, 2026 | -14.28 Mn |
| Dec 31, 2025 | 11.37 Mn |
| Dec 31, 2025 | 11.37 Mn |
| Sep 30, 2025 | -153.03 Mn |
| Sep 30, 2025 | -153.03 Mn |
| Jun 30, 2025 | 16.67 Mn |
| Jun 30, 2025 | 16.67 Mn |
| Mar 31, 2025 | 6.84 Mn |
| Mar 31, 2025 | 6.84 Mn |
| Dec 31, 2024 | 30.81 Mn |
| Dec 31, 2024 | 30.81 Mn |
| Sep 30, 2024 | -1.09 Mn |
| Sep 30, 2024 | -1.09 Mn |
| Jun 30, 2024 | 63.00 Mn |
| Jun 30, 2024 | 63.00 Mn |
| Mar 31, 2024 | 30.75 Mn |
| Mar 31, 2024 | 30.75 Mn |